Anticompetitive impact of pseudo-generics

Rodrigues, Vasco; Gonçalves, Ricardo; Vasconcelos, Hélder

Publication

Anticompetitive impact of pseudo-generics

2011Conference object

dc.contributor.author	Rodrigues, Vasco
dc.contributor.author	Gonçalves, Ricardo
dc.contributor.author	Vasconcelos, Hélder
dc.date.accessioned	2016-12-23T11:26:26Z
dc.date.available	2016-12-23T11:26:26Z
dc.date.issued	2011
dc.description.abstract	A puzzling feature of pharmaceuticals markets is that sellers of branded drugs will, sometimes, sell generic versions of their own branded products, either directly or through license agreements. This paper proposes a new theoretical rationale for the fact that the introduction of these pseudo- generics may have anti-competitive e¤ects. In a model that combines horizontal and vertical product di¤erentiation, we show that the producer of the branded product will not sell the pseudo-generic unless faced with competition and that, if she does so, in some circumstances, all prices raise to the bene t of all competitors and the detriment of consumers.	pt_PT
dc.description.version	info:eu-repo/semantics/publishedVersion	pt_PT
dc.identifier.citation	RODRIGUES, Vasco; GONÇALVES, Ricardo; VASCONCELOS, Hélder - Anticompetitive Impact of Pseudogenerics. - In 5th Annual Meeting of the Portuguese Economic Journal, Aveiro, Portugal, 8-9 July. – In Labour Economics 1. Aveiro: PEJ MEETING, 2011. 16p.	pt_PT
dc.identifier.uri	http://hdl.handle.net/10400.14/21162
dc.language.iso	eng	pt_PT
dc.rights.uri	http://creativecommons.org/licenses/by/4.0/	pt_PT
dc.subject	Pseudo-Generics	pt_PT
dc.subject	Product differentiation	pt_PT
dc.subject	Pharmaceutical pricing	pt_PT
dc.title	Anticompetitive impact of pseudo-generics	pt_PT
dc.type	conference object
dspace.entity.type	Publication
rcaap.rights	openAccess	pt_PT
rcaap.type	conferenceObject	pt_PT